Journal
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Volume 26, Issue 4, Pages 434-437Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/14767058.2012.733768
Keywords
Down syndrome; fetal DNA; maternal serum; non-invasive prenatal diagnosis; twin pregnancies
Categories
Ask authors/readers for more resources
Non-invasive prenatal screening for fetal Down syndrome (NIFTY) by maternal plasma sequencing was performed in 12 subjects with twin pregnancies, including 11 with normal fetuses and 1 with discordant fetal Trisomy 21. For every sample, it was processed, sequenced and reported as soon as it was collected as other clinical samples for singleton pregnancies. The NIFTY test was negative in the 11 pregnancies carried normal fetuses, and was positive (high risk) in the case with discordant fetal Trisomy 21. The sensitivity and specificity were both 100%. This small case series suggested the NIFTY as a screening test for fetal Trisomy 21 is feasible in twin pregnancies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available